Pulmonary Embolism, Pulmonary Microcirculation, and Thrombolytic Therapy

Sasahara, Arthur A.; Sharma, G.V.R.K.; Parisi, Alfred F.; Barsamian, Ernest M.; McIntyre, Kevin M.; Tow, Donald E.; Cella, Giuseppe
June 1982
Angiology;Jun1982, Vol. 33 Issue 6, p368
Academic Journal
This article presents a study on the thrombolytic therapy. The 40 patients selected for this study were those with pulmonary embolism confirmed by selective angiography who were entered into the 2 national cooperative studies of thrombolytic agents, sponsored by the National Heart, Lung, and Blood Institute. The first trial was a comparison of heparin and 12-hour urokinase treatments, while the second was a comparison of 12 and 24 hours of urokinase and 24 hours of streptokinase treatments, followed by heparin and oral anticoagulants.


Related Articles

  • THE PRESENT STATUS OF FIBRTNOLYTIC THERAPY. Eugene E. Cliffton // Angiology;Nov1963, Vol. 14 Issue 11, p533 

    Fibrinolytic therapy for thrombosis is effective in dissolution of the thrombus when started early and administered in adequate dosage. Its effect is probably increased by heparin and possibly by anticoagulants but the dangers of treatment arc also increased. The use of finis therapeutic agent...

  • High-Intensity Focused Ultrasound (HIFU) for Dissolution of Clots in a Rabbit Model of Embolic Stroke. Burgess, Alison; Huang, Yuexi; Waspe, Adam C.; Ganguly, Milan; Goertz, David E.; Hynynen, Kullervo; Schlachetzki, Felix // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    It is estimated that only 2-6% of patients receive thrombolytic therapy for acute ischemic stroke suggesting that alternative therapies are necessary. In this study, we investigate the potential for high intensity focused ultrasound (HIFU) to initiate thrombolysis in an embolic model of...

  • A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction... Julian, D.G.; Chamberlain, D.A. // BMJ: British Medical Journal (International Edition);12/07/96, Vol. 313 Issue 7070, p1429 

    Compares aspirin with anticoagulation with regard to risk of cardiac death and re-infarction in patients who received anistreplase thrombolysis for myocardial infarction. Absence of evidence in the incidence of cardiac events found between the two treatment groups; Higher incidence of severe...

  • Safety of diagnostic coronary angiogram by radial approach in patients on chronic anticoagulation therapy with coumarin derivatives. Mohandes, Mohsen; Colomer, Ingrid; De Castro, Ramón; Guarinos, Jordi; Rojas, Sergio; Fernández, Francisco; Bardaji, Alfredo // International Cardiovascular Research Journal;2012, Vol. 6 Issue 2, p36 

    Background: The use of radial access for diagnostic coronary angiogram and percutaneous coronary intervention (PCI) has increased during the last few years, especially due to its benefit regarding reduction in site vascular complication compared with femoral approach. Objectives: To evaluate the...

  • Management of Anticoagulant and Thrombolytic Agents in Deep Venous Thrombosis. Coon, William W. // Vascular Surgery;Jan/Feb1982, Vol. 16 Issue 1, p1 

    Presents a study on the management of anticoagulant and thrombolytic agents in deep venous thrombosis. Utilization of the heparin agent in treating the disease; Treatment with oral anticoagulants; Use of thrombolytic agents.

  • Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention. Wong, Graham C.; Giugliano, Robert P.; Antman, Elliott M. // JAMA: Journal of the American Medical Association;1/15/2003, Vol. 289 Issue 3, p331 

    Context: Low-molecular-weight heparins (LMWHs) possess several potential pharmacological advantages over unfractionated heparin as an antithrombotic agent. Objective: To systematically summarize the clinical data on the efficacy and safety of LMWHs compared with unfractionated heparin across the...

  • Intravascular Targeting of a New Anticoagulant Heparin Compound. Walderveen, Maria C. Van; Berry, Leslie R.; Chan, Anthony K. C. // Cardiovascular & Haematological Disorders - Drug Targets;Jun2009, Vol. 9 Issue 2, p149 

    Since most thrombotic reactions occur on the vessel wall, interaction of anticoagulants with vascular components is critical. Heparin (H) is the primary drug for treatment and prevention of thrombosis. To improve H's efficacy and bioavailability, a covalent complex of H and its biological...

  • Renal Artery Embolism Following Thombolytic Therapy for Prosthetic Valve Thrombosis. Moorthy, Nagaraja; Kumar, Sudeep; Kapoor, Aditya; Kumar, Sunil // Heart Views;Apr-Jun2011, Vol. 12 Issue 2, p81 

    The article describes a case of renal artery embolism following thrombolytic therapy for prosthetic valve thrombosis in a 34-year-old male patient. The patient has a history of chronic rheumatic heart disease for which he underwent both aortic and mitral valve replacement 4 years before...

  • Enoxaparin: A Review of its Use as Thromboprophylaxis in Acutely Ill, Nonsurgical Patients. Siddiqui, M. Asif A.; Wagstaff, Antona J. // Drugs;2005, Vol. 65 Issue 7, p1025 

    Enoxaparin (Clexane®, Lovenox®) is a low molecular weight heparin (LMWH) that has been widely used in the prevention of venous thromboembolism (VTE) in surgical patients. More recently, with the recognition of the high incidence of VTE in acutely ill medical (nonsurgical) patients,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics